author-photo

Dan Matso

University of Southern California

3

Papers

12

Citations

Citation Trend

Filter By

Papers (3) Sort By

Journal Conference Others

Active Combination Therapy of Bortezomib (Velcade) and Ibritumomab Tiuxetan (Zevalin) in an In Vivo Diffuse Large B-Cell Lymphoma Model.

2005 Blood
Show All
- Source
- Cite
- Save
Citations (10)
Low frequency of altered biodistribution detected by Indium-111 imaging prior to yttrium-90 ibritumomab tiuxetan radioimmunotherapy: Imaging registry results

2005 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Incidence of Altered Biodistribution Detected by Indium 111 ( 111 In) Imaging Prior to Yttrium 90 ( 90 Y) Ibritumomab Tiuxetan (Zevalin®) Radioimmunotherapy: Results from a Zevalin Imaging Registry.

2004 Blood
Show All
- Source
- Cite
- Save
Citations (2)